Teva Sees Annual Revenue Growth Over Next Several Years on Boost From New Medicines

By Kelly CloonanTeva Pharmaceutical Industries expects revenue to rise in the next few years, boosted by its focus on new medicines.The biopharmaceutical company said Wednesday it is targeting mid-single-digit revenue growth from 2026 to 2030. Teva is also aiming for $6 billion to $7 billion in ann…